AGRX - Agile Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
70.57M
Enterprise Value 3
42.95M
Trailing P/E
N/A
Forward P/E 1
-4.41
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
2.30
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-2.88

Trading Information

Stock Price History

Beta (3Y Monthly) -0.50
52-Week Change 355.96%
S&P500 52-Week Change 312.80%
52 Week High 31.7000
52 Week Low 30.5300
50-Day Moving Average 31.2125
200-Day Moving Average 31.2901

Share Statistics

Avg Vol (3 month) 3836.42k
Avg Vol (10 day) 31.11M
Shares Outstanding 559.3M
Float 30.97M
% Held by Insiders 11.27%
% Held by Institutions 154.21%
Shares Short (Sep 30, 2019) 4369.99k
Short Ratio (Sep 30, 2019) 40.34
Short % of Float (Sep 30, 2019) 41.27%
Short % of Shares Outstanding (Sep 30, 2019) 40.62%
Shares Short (prior month Aug 30, 2019) 4362.32k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-30.46%
Return on Equity (ttm)-63.89%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -14.9M
Net Income Avi to Common (ttm)-15.76M
Diluted EPS (ttm)-0.4200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.59M
Total Cash Per Share (mrq)0.24
Total Debt (mrq)249k
Total Debt/Equity (mrq)1.08
Current Ratio (mrq)6.07
Book Value Per Share (mrq)0.52

Cash Flow Statement

Operating Cash Flow (ttm)-14.33M
Levered Free Cash Flow (ttm)-8.26M